QIAGEN NV (QGEN)
48.32
-0.71
(-1.45%)
USD |
NYSE |
Feb 19, 16:00
48.64
+0.32
(+0.67%)
Pre-Market: 07:51
QIAGEN Price : 48.32 for Feb. 19, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| InflaRx NV | 0.8728 |
| CDT Equity, Inc. | 0.9303 |
| LENZ Therapeutics, Inc. | 12.05 |
| Liminatus Pharma, Inc. | 0.2383 |
| Oruka Therapeutics, Inc. | 32.42 |
Price Related Metrics
| PE Ratio | 23.64 |
| PS Ratio | 4.807 |
| PEG Ratio | 0.0564 |
| Price to Book Value | 2.635 |
| Price to Free Cash Flow | 22.47 |
| Earnings Yield | 4.23% |
| Market Cap | 9.954B |
| PEGY Ratio | 0.0554 |
| Operating PE Ratio | 19.26 |